TrialCancer immunology, immunotherapy : CII1995
High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets.
W C Mertens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.